Table 5. Smoking, alcohol, dietary folate and adenoma risk by genotype among all subjects.
Exposure variable | CA/CO | CA/CO | CA/CO | OR a,b,c | 95%CI | P | OR a,b,c | 95%CI | P | OR a,b,c | 95%CI | P |
LIG3 rs105236 | ||||||||||||
Alcohol Intake | CC | CT | TT | C/C | C/T | T/T | ||||||
Never | 97/108 | 99/106 | 34/30 | 1ref | 1ref | 1ref | ||||||
≤6 g/day | 67/81 | 73/76 | 31/38 | 1.05 | 0.70–1.58 | 0.818 | 0.90 | 0.67–1.22 | 0.499 | 0.77 | 0.44–1.35 | 0.369 |
>6 g/day | 89/61 | 99/99 | 23/38 | 1.77 | 1.17–2.68 | 0.006 | 1.01 | 0.75–1.36 | 0.962 | 0.57 | 0.32–1.01 | 0.053 |
p trend | 0.003 | 0.719 | 0.071 | |||||||||
interaction pd = 0.005; interaction pgene e = 0.019; interaction ppathway f = 0.241 | ||||||||||||
Alcoholic Drinks | CC | CT | TT | C/C | C/T | T/T | ||||||
Never | 97/108 | 99/106 | 34/30 | 1ref | 1ref | 1ref | ||||||
≤1 drink/day | 112/116 | 121/117 | 41/56 | 1.24 | 0.86–1.80 | 0.247 | 0.96 | 0.73–1.26 | 0.752 | 0.74 | 0.44–1.23 | 0.243 |
>1 drink/day | 44/26 | 51/58 | 13/20 | 1.84 | 1.09–3.11 | 0.022 | 0.97 | 0.67–1.38 | 0.848 | 0.51 | 0.25–1.01 | 0.052 |
p trend | 0.024 | 0.807 | 0.048 | |||||||||
interaction pd = 0.010; interaction pgene e = 0.029; interaction ppathway f = 0.345 | ||||||||||||
Folate mcg/day | CC | CT | TT | C/C | C/T | T/T | ||||||
≤267 | 106/101 | 110/92 | 36/26 | 1ref | 1ref | 1ref | ||||||
>267–387 | 65/85 | 84/89 | 31/38 | 0.77 | 0.52–1.15 | 0.205 | 0.74 | 0.55–0.99 | 0.040 | 0.70 | 0.40–1.23 | 0.215 |
≥388 | 82/64 | 77/100 | 21/42 | 1.29 | 0.86–1.93 | 0.212 | 0.69 | 0.51–0.93 | 0.015 | 0.37 | 0.20–0.65 | 0.001 |
p trend | 0.175 | 0.021 | <0.001 | |||||||||
interaction pd = 0.001; interaction pgene e = 0.006; interaction ppathway f = 0.081 | ||||||||||||
LIG3 rs3744358 | ||||||||||||
Folate mcg/day | TT | TG | GG | T/T | T/G | G/G | ||||||
≤267 | 139/128 | 91/79 | 22/12 | 1ref | 1ref | 1ref | ||||||
>267–387 | 81/117 | 74/74 | 26/19 | 0.66 | 0.46–0.94 | 0.022 | 0.83 | 0.59–1.16 | 0.269 | 1.05 | 0.54–2.04 | 0.890 |
≥388 | 103/100 | 65/80 | 11/26 | 1.07 | 0.75–1.53 | 0.719 | 0.63 | 0.45–0.90 | 0.010 | 0.38 | 0.19–0.75 | 0.006 |
p trend | 0.577 | 0.010 | 0.003 | |||||||||
interaction pd = 0.008; interaction pgene e = 0.032; interaction ppathway f = 0.451 | ||||||||||||
MUTYH rs10890324 | ||||||||||||
Smoking Pack-yrs | AA | AG | GG | A/A | A/G | G/G | ||||||
Never | 116/132 | 89/108 | 25/32 | 1ref | 1ref | 1ref | ||||||
>0–21 | 75/86 | 59/74 | 20/24 | 0.98 | 0.67–1.45 | 0.928 | 0.99 | 0.72–1.36 | 0.950 | 1.00 | 0.54–1.86 | 0.993 |
>21 | 95/99 | 89/64 | 44/18 | 1.02 | 0.70–1.49 | 0.903 | 1.76 | 1.29–2.42 | <0.001 | 3.03 | 1.67–5.51 | <0.001 |
p trend | 0.871 | <0.001 | <0.001 | |||||||||
interaction pd = 0.002; interaction pgene e = 0.007; interaction ppathway f = 0.091 | ||||||||||||
OGG1 rs159153 | ||||||||||||
Smoking Pack-yrs | TT | TC | CC | T/T | T/C | C/C | ||||||
Never | 116/139 | 96/106 | 18/27 | 1ref | 1ref | 1ref | ||||||
>0–21 | 86/91 | 52/75 | 15/16 | 1.06 | 0.73–1.55 | 0.746 | 0.95 | 0.67–1.33 | 0.747 | 0.84 | 0.42–1.66 | 0.615 |
>21 | 94/96 | 109/73 | 24/12 | 1.11 | 0.76–1.62 | 0.578 | 1.75 | 1.26–2.44 | 0.001 | 2.76 | 1.43–5.31 | 0.002 |
p trend | 0.610 | <0.001 | <0.001 | |||||||||
interaction pd = 0.013; interaction pgene e = 0.040; interaction ppathway f = 0.517 | ||||||||||||
FEN1 rs108499 | ||||||||||||
Smoking Pack-yrs | CC | CT | TT | C/C | C/T | T/T | ||||||
Never | 95/118 | 87/108 | 48/44 | 1ref | 1ref | 1ref | ||||||
>0–21 | 64/70 | 56/86 | 32/27 | 1.02 | 0.67–1.54 | 0.926 | 0.96 | 0.71–1.29 | 0.771 | 0.90 | 0.52–1.56 | 0.7 |
>21 | 124/79 | 82/78 | 21/22 | 1.99 | 1.36–2.91 | <0.001 | 1.25 | 0.92–1.71 | 0.156 | 0.79 | 0.44–1.41 | 0.424 |
p trend | <0.001 | 0.102 | 0.446 | |||||||||
interaction pd = 0.013; interaction pgene e = 0.039; interaction ppathway f = 0.507 |
Odds ratios (ORs) are from models with genotype coded as log-additive (treated as continuous) and adjusted for age, sex, clinic, exam date, study phase, and race among all study participants. Excludes 21 individuals who characterized their race/ethnic group as "other";
ORs for smoking additionally adjusted for alcohol intake (g/d) and dietary folate intake (mcg/day); ORs for alcohol additionally adjusted for smoking pack-years and dietary folate intake (mcg/d); ORs for dietary folate intake, additionally adjusted for alcohol intake (g/d) and smoking pack-years;
ORs derived from a common baseline model that included the SNP, smoking, alcohol, dietary folate exposure and interaction terms between genotype and smoking, alcohol, dietary folate exposure levels;
Crude interaction p-value;
Within gene region, Bonferroni adjusted interaction p-value, based on the number of SNPs within the respective gene region;
Pathway wide, Bonferroni adjusted interaction p-value, based on 14 investigated BER gene regions.